Rankings
▼
Calendar
PRME Q3 2021 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena
PRME
Prime Medicine, Inc.
$681M
Q3 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$10M
Net Income
-$16M
EPS (Diluted)
$-0.24
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$11M
Stock-Based Comp.
$339,000
Balance Sheet
Total Assets
$315M
Total Liabilities
$14M
Stockholders' Equity
$301M
Cash & Equivalents
$201M
← FY 2021
All Quarters
Q4 2021 →